Smoking Behavior and Healthcare Expenditure in the United States, 1992–2009: Panel Data Estimates
James Lightwood and Stanton Glantz report on a modeling study in which health spending across US States during 1992–2009 was studied as a function of smoking prevalence, indicating that reduced smoking could yield substantial early benefits in healthcare expenditure as well as long-term improvements in health.
Vyšlo v časopise:
Smoking Behavior and Healthcare Expenditure in the United States, 1992–2009: Panel Data Estimates. PLoS Med 13(5): e32767. doi:10.1371/journal.pmed.1002020
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002020
Souhrn
James Lightwood and Stanton Glantz report on a modeling study in which health spending across US States during 1992–2009 was studied as a function of smoking prevalence, indicating that reduced smoking could yield substantial early benefits in healthcare expenditure as well as long-term improvements in health.
Zdroje
1. US Department of Health and Human Services (2014) The health consequences of smoking—50 years of progress: a report of the Surgeon General. Rockville (Maryland): US Department of Health and Human Services.
2. Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, et al. (2015) Smoking and mortality—beyond established causes. N Engl J Med 372: 631–640. doi: 10.1056/NEJMsa1407211 25671255
3. Lightwood JM, Glantz SA (1997) Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 96: 1089–1096. 9286934
4. Lightwood JM, Phibbs CS, Glantz SA (1999) Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics 104: 1312–1320. 10585982
5. Pelkonen M, Notkola I, Tukiainen H, Tervahauta M, Tuomilehto J, et al. (2001) Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study. Thorax 56: 703–707. 11514691
6. Sloan FA, Ostermann J, Picone G, Conover C, Taylor D Jr (2004) The price of smoking. Cambridge (Massachusetts): MIT Press.
7. Vander Weg MW, Rosenthal GE, Vaughan Sarrazin M (2012) Smoking bans linked to lower hospitalizations for heart attacks and lung disease among Medicare beneficiaries. Health Aff (Millwood) 31: 2699–2707.
8. Been JV, Nurmatov UB, Cox B, Nawrot TS, van Schayck CP, et al. (2014) Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. Lancet 383: 1549–1560. doi: 10.1016/S0140-6736(14)60082-9 24680633
9. Millett C, Lee JT, Laverty AA, Glantz SA, Majeed A (2013) Hospital admissions for childhood asthma after smoke-free legislation in England. Pediatrics 131: e495–e501. doi: 10.1542/peds.2012-2592 23339216
10. Barnoya J, Glantz S (2004) Association of the California tobacco control program with declines in lung cancer incidence. Cancer Causes Control 15: 689–695. 15280627
11. Pierce JP, Messer K, White MM, Kealey S, Cowling DW (2010) Forty years of faster decline in cigarette smoking in California explains current lower lung cancer rates. Cancer Epidemiol Biomarkers Prev 19: 2801–2810. doi: 10.1158/1055-9965.EPI-10-0563 20852009
12. Lightwood JM, Dinno A, Glantz SA (2008) Effect of the California tobacco control program on personal health care expenditures. PLoS Med 5: e178. doi: 10.1371/journal.pmed.0050178 18752344
13. Lightwood J, Glantz S (2013) The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1985–2008. PLoS ONE 8: e47145. doi: 10.1371/journal.pone.0047145 23418411
14. Lightwood J, Glantz S (2011) Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures. Soc Sci Med 72: 166–172. doi: 10.1016/j.socscimed.2010.11.015 21168248
15. Ebarhardt M (2009) Nonstationary panel econometrics and common factor models: an introductory reader. Oxford: Oxford University Department of Economics. 60 pp.
16. Kapetanios G, Pesaran M, Yamagata T (2009) Panels with nonstationary multifactor error structures. Cambridge: University of Cambridge Department of Economics.
17. Pesaran M (2006) Estimation and inference in large heterogeneous panels with a multifactor error structure. Econometrica 74: 967–1012.
18. Centers for Medicare and Medicaid Services (2011) Health spending by state of residence, 1991–2009. Baltimore: Centers for Medicare and Medicaid Services. Available: https://www.cms.gov/mmrr/Downloads/MMRR2011_001_04_a03-.pdf. Accessed 29 December 2015.
19. Centers for Disease Control and Prevention (2016) State Tobacco Activities Tracking and Evaluation (STATE) System. Atlanta: Centers for Disease Control and Prevention. Available: http://nccd.cdc.gov/STATESystem/rdPage.aspx?rdReport=OSH_State.CustomReports. Accessed 12 April 2016.
20. Orzechowski W, Walker RC (2009) The tax burden on tobacco, vol. 44. Arlington (Virginia): Orzechowski & Walker.
21. United States Census Bureau (2016) State population estimates and demographic components of change: 1980 to 1990, by single year of age and sex. Washington (District of Columbia): United States Census Bureau. Available: http://www.census.gov/popest/data/state/asrh/1980s/80s_st_age_sex.html. Accessed 12 April 2016.
22. United States Census Bureau (2016) Population estimates: single year of age by sex. Washington (District of Columbia): United States Census Bureau. Available: http://www.census.gov/popest/data/state/asrh/1990s/st_age_sex.html. Accessed 12 April 2016.
23. United States Census Bureau (2012) Downloadable datasets: intercensal estimates of the resident population by single year of age and sex for states and the United States: April 1, 2000 to July 1, 2010. Washington (District of Columbia): United States Census Bureau. Available: http://www.census.gov/popest/data/intercensal/state/state2010.html. Accessed 7 December 2015.
24. Centers for Disease Control and Prevention (2016) Behavioral Risk Factor Surveillance System: survey data and documentation. US Department of Health and Human Services, Centers for Disease Control and Prevention. Available: http://www.cdc.gov/brfss/data_documentation/index.htm. Accessed 12 April 2016.
25. Bureau of Economic Analysis (2016) Regional data: GDP and personal income. Available: http://www.bea.gov/iTable/iTable.cfm?reqid=70&step=1&isuri=1&acrdn=6#reqid=70&step=1&isuri=1. Accessed 12 April 2016.
26. Bureau of Labor Statistics (2015) Consumer price index—all urban consumers (current series). Washington (District of Columbia): Bureau of Labor Statistics. Available: http://data.bls.gov/PDQ/outside.jsp?survey=cu. Accessed 12 September 2015.
27. Bureau of Economic Analysis (2016) Regional economic accounts: methodologies. Washington (District of Columbia): Bureau of Economic Analysis. Available: http://www.bea.gov/regional/methods.cfm. Accessed 12 April 2016.
28. Fix B, Hyland A, O’Connor R, Cummings K, Fong G, et al. (2013) A novel approach to estimating the prevalence of untaxed cigarettes in the USA: findings from the 2009 and 2010 international tobacco control surveys. BMJ 23: i61–i66.
29. Davis K, Grimshaw V, Merriman D, Farrelly M, Chernick H, et al. (2014) Cigarette trafficking in five northeastern US cities. Tob Control 23: e62–e68. doi: 10.1136/tobaccocontrol-2013-051244 24335338
30. Centers for Medicare and Medicaid Services (2016) NHE summary including share of GDP, CY 1960–2014. Available: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsHistorical.html. Accessed 12 April 2016.
31. Max W, Rice D, Sung H, Zhang X, Miller L (2004) The economic burden of smoking in California. Tob Control 13: 264–267. 15333882
32. Burton A (2011) Does the smoke ever clear? Environ Health Perspect 119: A71–A74.
33. Max W, Sung H, Lightwood J (2013) The impact of changes in tobacco control funding on healthcare expenditures in California, 2012–2016. Tob Control 22: e10–5.
34. Warner KE, Fulton GA, Nicolas P, Grimes DR (1996) Employment implications of declining tobacco product sales for the regional economies of the United States. JAMA 275: 1241–1246. 8601955
35. Max W (2001) The financial impact of smoking on health-related costs: a review of the literature. Am J Health Promot 15: 321–331. 11502013
36. Leistikow BN (2009) Smoking and ischemic heart disease disparities between studies, genders, times, and socioeconomic strata. J Cardiovasc Transl Res 2: 267–273. doi: 10.1007/s12265-009-9113-x 19654885
37. Leistikow BN (2009) Are most cancer deaths in more developed nations now from smoking? Recent smoke load/cancer death association trends. Future Oncol 5: 413–416. doi: 10.2217/fon.09.27 19450169
38. Leistikow BN, Kabir Z, Connolly GN, Clancy L, Alpert HR (2008) Male tobacco smoke load and non-lung cancer mortality associations in Massachusetts. BMC Cancer 8: 341. doi: 10.1186/1471-2407-8-341 19025639
39. Leistikow BN, Martin DC, Samuels SJ (2000) Injury death excesses in smokers: a 1990–95 United States national cohort study. Inj Prev 6: 277–280. 11144627
40. Leistikow BN, Shipley MJ (1999) Might stopping smoking reduce injury death risks? A meta-analysis of randomized, controlled trials. Prev Med 28: 255–259. 10072743
41. US Department of Health and Human Services (2004) The health consequences of smoking: a report of the Surgeon General. Atlanta: US Department of Health and Human Services.
42. US Department of Health and Human Services (2006) The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta: US Department of Health and Human Services.
43. US Department of Health and Human Services (2010) How tobacco smoke causes disease—the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Atlanta: US Department of Health and Human Services.
44. US Department of Health and Human Services (2010) Women and smoking: a report of the Surgeon General. Atlanta: US Department of Health and Human Services.
45. Warner KE, Hodgson TA, Carroll CE (1999) Medical costs of smoking in the United States: estimates, their validity, and their implications. Tob Control 8: 290–300. 10599574
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2016 Číslo 5
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain
- Prioritizing Surgical Care on National Health Agendas: A Qualitative Case Study of Papua New Guinea, Uganda, and Sierra Leone
- A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact
- Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola